Balyasny Asset Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-58,897
Closed -$3.08M 2908
2024
Q2
$3.08M Sell
58,897
-336,523
-85% -$14.8M 0.01% 1376
2024
Q1
$16.1M Buy
395,420
+298,985
+310% +$11.2M 0.03% 724
2023
Q4
$3.56M Sell
96,435
-117,536
-55% -$4.43M 0.01% 1250
2023
Q3
$8.17M Sell
213,971
-54,860
-20% -$2.25M 0.02% 922
2023
Q2
$9.7M Sell
268,831
-7,298
-3% -$249K 0.02% 797
2023
Q1
$10.5M Buy
276,129
+214,592
+349% +$10.1M 0.03% 753
2022
Q4
$3.5M Sell
61,537
-57,869
-48% -$2.96M 0.01% 1174
2022
Q3
$4.72M Buy
+119,406
New +$5.28M 0.01% 1031
2022
Q1
Sell
-7,070
Closed -$284K 2621
2021
Q4
$284K Sell
7,070
-149,460
-95% -$5.58M ﹤0.01% 1757
2021
Q3
$6.37M Sell
156,530
-108,298
-41% -$4.53M 0.03% 740
2021
Q2
$12M Buy
+264,828
New +$11.7M 0.06% 448
2021
Q1
Sell
-31,643
Closed -$1.35M 1892
2020
Q4
$1.35M Buy
+31,643
New +$1.14M 0.01% 951
2018
Q2
Sell
-40,005
Closed -$784K 1918
2018
Q1
$784K Buy
+40,005
New +$775K ﹤0.01% 1309
2016
Q2
Sell
-13,500
Closed -$128K 1275
2016
Q1
$128K Buy
+13,500
New +$127K ﹤0.01% 1181
2015
Q1
Sell
-758,645
Closed -$7.32M 995
2014
Q4
$7.32M Buy
+758,645
New +$6.74M 0.07% 360

Other funds holding HALO

Balyasny Asset Management's HALO Position: Q3 2024 in Review

Balyasny Asset Management sold out of Halozyme (HALO) in Q3 2024, closing a stake of 58,897 shares — an estimated $3.08M sold.

Balyasny Asset Management first reported a position in HALO in Q4 2014 and held it in 15 quarters. The position peaked at $16.1M in Q1 2024. 508 funds tracked by Wall St. Rank hold HALO as of Q3 2024.

  • Balyasny Asset Management reported no remaining Halozyme position as of Q3 2024 after selling out during the quarter.
  • Balyasny Asset Management sold 58,897 Halozyme shares in Q3 2024, an estimated $3.08M.
  • Balyasny Asset Management first reported a position in Halozyme in Q4 2014 and held it in 15 quarters.
  • Balyasny Asset Management's Halozyme position peaked at $16.1M in Q1 2024.
  • 508 funds tracked by Wall St. Rank held Halozyme as of Q3 2024.

Based on Balyasny Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.